Literature DB >> 20051462

Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study.

Deborah E Barnes1, Thaddeus J Haight, Kala M Mehta, Michelle C Carlson, Lewis H Kuller, Ira B Tager.   

Abstract

Recent studies have found that smoking is associated with an increased risk of dementia, but the effects of secondhand smoke (SHS) on dementia risk are not known to have previously been studied. The authors used Cox proportional hazards marginal structural models to examine the association between self-reported lifetime household SHS exposure and risk of incident dementia over 6 years among 970 US participants in the Cardiovascular Health Cognition Study (performed from 1991 to 1999) who were never smokers and were free of clinical cardiovascular disease (CVD), dementia, and mild cognitive impairment at baseline. In addition, because prior studies have found that SHS is associated with increased risk of CVD and that CVD is associated with increased risk of dementia, the authors tested for interactions between SHS and measures of clinical and subclinical CVD on dementia risk. Moderate (16-25 years) and high (>25 years) SHS exposure levels were not independently associated with dementia risk; however, subjects with >25 years of SHS exposure and >25% carotid artery stenosis had a 3-fold increase (hazard ratio = 3.00, 95% confidence interval: 1.03, 9.72) in dementia risk compared with subjects with no/low (0-15 years) SHS exposure and < or =25% carotid artery stenosis. High lifetime SHS exposure may increase the risk of dementia in elderly with undiagnosed CVD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051462      PMCID: PMC2878108          DOI: 10.1093/aje/kwp376

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  41 in total

1.  No adjustments are needed for multiple comparisons.

Authors:  K J Rothman
Journal:  Epidemiology       Date:  1990-01       Impact factor: 4.822

Review 2.  Exposure to passive cigarette smoking and child development. A critical review.

Authors:  D Rush; K R Callahan
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Identifiability and exchangeability for direct and indirect effects.

Authors:  J M Robins; S Greenland
Journal:  Epidemiology       Date:  1992-03       Impact factor: 4.822

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

5.  Toward a clearer definition of confounding.

Authors:  C R Weinberg
Journal:  Am J Epidemiol       Date:  1993-01-01       Impact factor: 4.897

6.  A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study.

Authors:  R N Bryan; T A Manolio; L D Schertz; C Jungreis; V C Poirier; A D Elster; R A Kronmal
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

7.  Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study.

Authors:  T A Manolio; R A Kronmal; G L Burke; V Poirier; D H O'Leary; J M Gardin; L P Fried; E P Steinberg; R N Bryan
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

Review 8.  Smoking and Alzheimer's disease: a review of the epidemiological evidence.

Authors:  P N Lee
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

9.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

10.  Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; S J Kittner; M G Bond; S K Wolfson; W Bommer; T R Price; J M Gardin; P J Savage
Journal:  Stroke       Date:  1992-12       Impact factor: 7.914

View more
  21 in total

1.  Exposure to secondhand tobacco smoke and the frailty syndrome in US older adults.

Authors:  Esther García-Esquinas; Ana Navas-Acien; Fernando Rodríguez-Artalejo
Journal:  Age (Dordr)       Date:  2015-03-15

Review 2.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Smoke-Free Multi-unit Housing Policies Show Promise in Reducing Secondhand Smoke Exposure Among Racially and Ethnically Diverse, Low-Income Seniors.

Authors:  T Lucas Hollar; Nicole Cook; David Quinn; Teina Phillips; Michael DeLucca
Journal:  J Immigr Minor Health       Date:  2017-12

4.  Smoking, death, and Alzheimer disease: a case of competing risks.

Authors:  Chung-Chou H Chang; Yongyun Zhao; Ching-Wen Lee; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

5.  Cardiovascular Disease Risk Factors and Cognition in the Elderly.

Authors:  Elizabeth C Leritz; Regina E McGlinchey; Ida Kellison; James L Rudolph; William P Milberg
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-10

Review 6.  The projected effect of risk factor reduction on Alzheimer's disease prevalence.

Authors:  Deborah E Barnes; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2011-07-19       Impact factor: 44.182

7.  Relative contributions of biomarkers in Alzheimer's disease.

Authors:  Thaddeus J Haight; William J Jagust
Journal:  Ann Epidemiol       Date:  2012-10-24       Impact factor: 3.797

8.  Association of blood cotinine level with cognitive and physical performance in non-smoking older adults.

Authors:  Wajiha Z Akhtar; Elena M Andresen; Michael B Cannell; Xiaohui Xu
Journal:  Environ Res       Date:  2012-11-28       Impact factor: 6.498

9.  Exploration of the Global Burden of Dementia Attributable to PM2.5: What Do We Know Based on Current Evidence?

Authors:  Muye Ru; Michael Brauer; Jean-François Lamarque; Drew Shindell
Journal:  Geohealth       Date:  2021-05-01

Review 10.  Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives.

Authors:  Bin-Lu Sun; Yang Chen; Dong-Yu Fan; Chi Zhu; Fan Zeng; Yan-Jiang Wang
Journal:  Sci China Life Sci       Date:  2020-10-23       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.